Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1999 | 03-1999 | 12-1998 | 09-1998 | 06-1998 | |
| Operating Expenses | 1,360 | 1,620 | 2,100 | 1,770 | 1,920 |
| Operating Income | -1,360 | -1,620 | -2,100 | -1,770 | -1,920 |
| Other Income | -270 | -450 | 170 | 180 | 190 |
| Pre-tax Income | -1,630 | -2,070 | -1,930 | -1,590 | -1,730 |
| Net Income Continuous | -1,636 | -2,079 | -1,917 | -1,596 | -1,735 |
| Net Income | $-1,636 | $-2,079 | $-1,917 | $-1,596 | $-1,735 |
| EPS Basic Total Ops | -2,750.00 | -11,500.00 | -3,500.00 | -3,000.00 | -3,250.00 |
| EPS Basic Continuous Ops | -2,750.00 | -11,500.00 | -3,500.00 | -3,000.00 | -3,250.00 |
| EPS Diluted Total Ops | -0.55 | -2.30 | -0.70 | -0.60 | -0.65 |
| EPS Diluted Continuous Ops | -2,726.67 | -4,158.00 | -3,834.00 | -3,192.00 | -3,470.00 |
| EBITDA(a) | $-1,355 | $-1,615 | $-2,080 | $-1,750 | $-1,900 |